Biora Therapeutics, Inc. (BIORQ)
$0.00
$-0.22
(-99.95%)
As on 05-Nov-2026 16:00EST
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biora Therapeutics, Inc (BIORQ)
| -- | -- | 0.0 | 0.0 | -98.3 | -95.9 | -- |
|
BSE Sensex*
| -4.3 | 11.9 | 3.1 | -2.9 | 8.0 | 6.2 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Biora Therapeutics, Inc (BIORQ)
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal... tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On May 27, 2025, the voluntary petition of Biora Therapeutics, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on December 27, 2024. Read more
-
CEO & Director
Mr. Aditya P. Mohanty M.B.A.
-
CEO & Director
Mr. Aditya P. Mohanty M.B.A.
-
Headquarters
San Diego, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Biora Therapeutics, Inc (BIORQ)
What is the current share price of Biora Therapeutics, Inc (BIORQ) Today?
The share price of Biora Therapeutics, Inc (BIORQ) is $0.00 (NASDAQ) as of 05-Nov-2026 16:00 EST. Biora Therapeutics, Inc (BIORQ) has given a return of -98.26% in the last 3 years.
What is the current PB & PE ratio of Biora Therapeutics, Inc (BIORQ)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-0.02 |
-0.02 |
2022 |
0.00 |
0.00 |
2021 |
-0.01 |
-0.02 |
2020 |
-0.01 |
-0.01 |
2019 |
-- |
-- |
What is the 52 Week High and Low of Biora Therapeutics, Inc (BIORQ)?
The 52-week high and low of Biora Therapeutics, Inc (BIORQ) are Rs 0.22 and Rs 0.00 as of 08-Nov-2026.
What is the market cap of Biora Therapeutics, Inc (BIORQ)?
Biora Therapeutics, Inc (BIORQ) has a market capitalisation of $ 0 Mln as on 30-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Biora Therapeutics, Inc (BIORQ)?
Before investing in Biora Therapeutics, Inc (BIORQ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.